41 results
Page 2 of 3
20-F/A
EX-4.38
d9ngh2rez7j
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
9b9wssk0hdye7h3p4o
23 Mar 15
Annual report (foreign) (amended)
12:00am
6-K
EX-99.1
0j05vj1
5 Mar 15
Current report (foreign)
12:00am
6-K
EX-99
joq5l fvfdl80iemc
24 Dec 14
Current report (foreign)
12:00am
6-K
EX-1.1
26khwv pbu4z
30 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
ou0k59f0 a6m3s
3 Mar 14
Current report (foreign)
12:00am
424B3
4ziks0
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-10.1
lwcan
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
424B3
egoeatb
15 Oct 12
Prospectus supplement
12:00am
F-1
lna7icnc0wxtcmn
2 Oct 12
Registration statement (foreign)
12:00am
6-K
EX-99
m9py1p gvc
27 Sep 12
Current report (foreign)
12:00am
424B3
06qclozob401lfpokew
28 Mar 12
Prospectus supplement
12:00am
20-F
xgvd 0rtuu8uv
22 Mar 12
Annual report (foreign)
12:00am
6-K
EX-99.2
9c3bdv7ica8
16 Feb 12
Current Report, Foreign Issuer
12:00am
20FR12B/A
ihin41vefu0
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
eouecfqox3svi yq5
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am